Cargando…

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List

OBJECTIVES: Challenges remain in ensuring universal access to affordable essential medicines. We previously estimated the expected generic prices based on cost of production for medicines in solid oral formulations (ie, capsules or tablets) on the WHO Model List of Essential Medicines (EML). The obj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gotham, Dzintars, Barber, Melissa Joy, Hill, Andrew M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773329/ https://www.ncbi.nlm.nih.gov/pubmed/31575568 http://dx.doi.org/10.1136/bmjopen-2018-027780

Ejemplares similares

Estimated costs of production and potential prices for the WHO Essential Medicines List
por: Hill, Andrew M, et al.
Publicado: (2018)

Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis
por: Hill, Andrew, et al.
Publicado: (2017)

Production costs and potential prices for biosimilars of human insulin and insulin analogues
por: Gotham, Dzintars, et al.
Publicado: (2018)

Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
por: Barber, Melissa J., et al.
Publicado: (2020)

Monographs for medicines on WHO’s Model List of Essential Medicines
por: Roth, Lukas, et al.
Publicado: (2018)

Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
por: Hill, Andrew, et al.
Publicado: (2016)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment
por: Hill, Andrew, et al.
Publicado: (2016)

Cross-country and panel data estimates of the price elasticity of demand for cigarettes in Europe
por: Kohler, Andreas, et al.
Publicado: (2023)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

Patent pooling to increase access to essential medicines
por: Burrone, Esteban, et al.
Publicado: (2019)

Real price of health-experiences of out-of-pocket costs in Australia: protocol for a systematic review
por: Wang, Shelley Ting-Li, et al.
Publicado: (2022)

Role of healthcare cost accounting in pricing and reimbursement in low-income and middle-income countries: a scoping review
por: Guinness, Lorna, et al.
Publicado: (2022)

Revising the WHO Essential Medicines List for paediatric rheumatology
por: Scott, Christiaan, et al.
Publicado: (2021)

Estimates of price and income elasticity in Greece. Greek debt crisis transforming cigarettes into a luxury good: an econometric approach
por: Tarantilis, Filippos, et al.
Publicado: (2015)

Impact of price and non-price policies on household cigarette consumption and nutrient intake in smoking-tolerant Indonesia
por: Djutaharta, Triasih, et al.
Publicado: (2021)

Modelling the cost of community interventions to reduce child mortality in South Africa using the Lives Saved Tool (LiST)
por: Nkonki, Lungiswa, LL, et al.
Publicado: (2017)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019)

Overweight and obesity on the island of Ireland: an estimation of costs
por: Dee, Anne, et al.
Publicado: (2015)

Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis
por: Jiang, Y, et al.
Publicado: (2019)

Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
por: Husain, Muhammad Jami, et al.
Publicado: (2020)

The Consistency Between the Chinese Essential Medicines List and Treatment Guidelines—Taking Oncology Medicines as an Example
por: Cheng, Luyan, et al.
Publicado: (2022)

Revising the WHO Essential Medicines List for paediatric rheumatology update
por: Slamang, Waheba, et al.
Publicado: (2022)

Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries
por: Hill, Andrew, et al.
Publicado: (2015)

Correction to: Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
Publicado: (2020)

Determinants of drug prices: a systematic review of comparison studies
por: Janssen Daalen, Jules M, et al.
Publicado: (2021)

Prevalence-based, disease-specific estimate of the social cost of smoking in Singapore
por: Cher, Boon Piang, et al.
Publicado: (2017)

Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan
por: Bibi, Murad, et al.
Publicado: (2022)

Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
por: Zheng, Fangfang, et al.
Publicado: (2018)

Access and use of WHO essential medicines in Italy
por: Petrella, Alessandro, et al.
Publicado: (2023)

Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren's contracture: a retrospective cohort study
por: Atroshi, Isam, et al.
Publicado: (2014)

The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke
por: van Eeden, M, et al.
Publicado: (2015)

Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority
por: Mori, Amani Thomas, et al.
Publicado: (2018)

Price elasticity of tobacco products among economic classes in India, 2011–2012
por: Selvaraj, Sakthivel, et al.
Publicado: (2015)

Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007–2017
por: Huang, Shao-Yi, et al.
Publicado: (2020)

Estimating the costs of blindness and moderate to severe visual impairment among people with diabetes in India
por: Redding, Stuart, et al.
Publicado: (2023)

Analysing actual prices of medical products: a cross-sectional survey of Dutch hospitals
por: den Ambtman, Anouk, et al.
Publicado: (2020)

Access to essential medicines for children: a cross-sectional survey measuring medicine prices, availability and affordability in Hanam province, Vietnam
por: Dinh, Dai Xuan, et al.
Publicado: (2021)

Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls
por: Aebersold, Helena, et al.
Publicado: (2023)

NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
por: Di Cesare, Mariachiara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i10naevvn49sen5v2j0mnnh41c